Giant Biogene Holding Co., Ltd.

HKSE 2367.HK

Giant Biogene Holding Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2023: 15,582.15

Giant Biogene Holding Co., Ltd. Interest Coverage Ratio is 15,582.15 for the year ending December 31, 2023, a -72.22% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Giant Biogene Holding Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2022 was 56,084.29.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
HKSE: 2367.HK

Giant Biogene Holding Co., Ltd.

CEO Mr. Jianya Yan
IPO Date Nov. 4, 2022
Location China
Headquarters No. 1855, Shanglin Yuan
Employees 1,512
Sector Health Care
Industries
Biotechnology Cosmetics Pharmaceuticals
Description

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.

StockViz Staff

January 15, 2025

Any question? Send us an email